The article reports findings on how Interleukin-25 (IL-25) treatment induces long-lasting changes in the small intestine, leading to enhanced mucosal immunity. Specifically, the researchers identify a population of memory type 2 innate lymphoid cells (ILC2s), termed effector-memory ILC2s, that are essential for establishing and maintaining this intestinal adaptation. These modified ILC2s exhibit d...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
